Brief: NovelStem Increases NewStem Ownership To 33%, Prepares For FDA Filing For Approval Of Its Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic

Novelstem International

01/12/2020 13:38

Dec 1 (Reuters) - Novelstem International Corp  NSTM.PK :
    * NOVELSTEM INCREASES NEWSTEM OWNERSHIP TO 33% AS NEWSTEM
PREPARES
FOR FIRST-HALF 2021 FDA FILING FOR APPROVAL OF ITS STEM-CELL
BASED ANTI-CANCER DRUG RESISTANCE DIAGNOSTIC; NOVELSTEM
INITIATES PROCESS TO BECOME PUBLICLY-REPORTING  WITH S.E.C. AND
TO UP-LIS

Source text for Eikon:  ID:nGNXb0ss0D 
Further company coverage:  NSTM.PK 

 ((Reuters.Briefs@thomsonreuters.com;))